Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars vs originators: Are they the same?
Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z. Sarzi-Puttini P, et al. Among authors: szekanecz z. Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Autoimmun Rev. 2019. PMID: 31639517 Review.
Cardiac manifestations in antiphospholipid syndrome.
Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Soltész P, et al. Among authors: szekanecz z. Autoimmun Rev. 2007 Jun;6(6):379-86. doi: 10.1016/j.autrev.2007.01.003. Epub 2007 Jan 31. Autoimmun Rev. 2007. PMID: 17537384 Review.
Controversies in rheumatism and autoimmunity.
Doria A, Putterman C, Sarzi-Puttini P, Szekanecz Z, Shoenfeld Y. Doria A, et al. Among authors: szekanecz z. Autoimmun Rev. 2012 Jun;11(8):555-7. doi: 10.1016/j.autrev.2011.10.023. Epub 2011 Oct 25. Autoimmun Rev. 2012. PMID: 22056979 No abstract available.
Malignancies associated with systemic sclerosis.
Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z. Szekanecz É, et al. Among authors: szekanecz z. Autoimmun Rev. 2012 Oct;11(12):852-5. doi: 10.1016/j.autrev.2012.02.021. Epub 2012 Mar 5. Autoimmun Rev. 2012. PMID: 22410174 Review.
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT. Agca R, et al. Among authors: szekanecz z. Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Ann Rheum Dis. 2017. PMID: 27697765 Review.
Effects of targeted therapies on the bone in arthritides.
Szentpétery Á, Horváth Á, Gulyás K, Pethö Z, Bhattoa HP, Szántó S, Szücs G, FitzGerald O, Schett G, Szekanecz Z. Szentpétery Á, et al. Among authors: szekanecz z. Autoimmun Rev. 2017 Mar;16(3):313-320. doi: 10.1016/j.autrev.2017.01.014. Epub 2017 Jan 31. Autoimmun Rev. 2017. PMID: 28159704 Review.
371 results